Lifeline Biotechnologies updates company's information on Pinks Sheets

Lifeline Biotechnologies, Inc. (Pink Sheets:LLBO) today announced that it has completed the updating of the Company’s information on Pinks Sheets.

Jim Holmes, Lifeline’s CEO, said, “The ‘Stop Sign’ on our Company site at Pink Sheets has been removed. The information filed with Pinks Sheets this past week was sufficient to remove the ‘Stop Sign’. The information submitted includes a Balance Sheet, Statement of Operations and Outstanding Common Shares as of June 30, 2009. This information can be seen on Lifeline’s Pink Sheet’s site at www.pinksheets.com. Then enter Lifeline’s trading symbol, LLBO then click on ‘FILINGS’.

“We have had questions on our current FDA filing. We await the FDA’s response, which could be received as early as the end of September. However, that is probably optimistic and it could be some additional 30 to 45 days before we receive the FDA’s response. As soon as we have the response we expect to release the information to the public.

“We’ve also received many questions concerning the prospect of a reverse split of the common stock. We have no plans to reverse split Lifeline’s common stock."

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.